MARATTO

review · Journal of Pharmaceutical Policy and Practice

Prevalence of substandard, falsified, unlicensed and unregistered medicine and its associated factors in Africa: a systematic review

202427 citationsOpen accessBahir Dar University

Abstract

Substandard, falsified, and unregistered medicines are highly prevalent in Africa, and attention has not been paid to the problem. Antibiotics, antimalarial, anthelmintic, and antiprotozoal are the most commonly reported substandard, falsified, and unregistered medicines. A consistent supply of high-quality products, enhancement of registration, market regulatory permission, and importation standards are essential to counter the problems in Africa. Preventing these problems is the primary duty of every responsible nation to save lives.

Research topics

  • Pharmaceutical Quality and Counterfeiting
  • Pharmaceutical Economics and Policy
  • Intellectual Property and Patents

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/20523211.2024.2375267

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.